Gene symbol: Ccn1

Also known as: Cyr61

Organism: Rattus norvegicus

Summary: Predicted to enable extracellular matrix binding activity; heparin binding activity; and integrin binding activity. Involved in cell adhesion; chemotaxis; and positive regulation of cytokine production. Predicted to be located in extracellular region. Predicted to be active in extracellular matrix. Orthologous to human CCN1 (cellular communication network factor 1). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 83476 AllianceGenome:RGD:620763


GO Annotation


Category Term ID Term description
Process GO:0000003 Reproduction
Process GO:0001501 Skeletal system development
Process GO:0001503 Ossification
Process GO:0001525 Angiogenesis
Process GO:0001568 Blood vessel development
Process GO:0001649 Osteoblast differentiation
Process GO:0001701 In utero embryonic development
Process GO:0001817 Regulation of cytokine production
Process GO:0001819 Positive regulation of cytokine production
Process GO:0001890 Placenta development
Process GO:0001892 Embryonic placenta development
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0001944 Vasculature development
Process GO:0002009 Morphogenesis of an epithelium
Process GO:0002011 Morphogenesis of an epithelial sheet
Process GO:0002041 Intussusceptive angiogenesis
Process GO:0003006 Developmental process involved in reproduction
Process GO:0003007 Heart morphogenesis
Process GO:0003170 Heart valve development
Process GO:0003171 Atrioventricular valve development
Process GO:0003179 Heart valve morphogenesis
Process GO:0003181 Atrioventricular valve morphogenesis
Process GO:0003205 Cardiac chamber development
Process GO:0003206 Cardiac chamber morphogenesis
Process GO:0003209 Cardiac atrium morphogenesis
Process GO:0003230 Cardiac atrium development
Process GO:0003231 Cardiac ventricle development
Process GO:0003278 Apoptotic process involved in heart morphogenesis
Process GO:0003279 Cardiac septum development
Process GO:0003281 Ventricular septum development
Process GO:0003283 Atrial septum development
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006357 Regulation of transcription by RNA polymerase II
Process GO:0006915 Apoptotic process
Process GO:0006935 Chemotaxis
Process GO:0006950 Response to stress
Process GO:0007154 Cell communication
Process GO:0007155 Cell adhesion
Process GO:0007165 Signal transduction
Process GO:0007275 Multicellular organism development
Process GO:0007507 Heart development
Process GO:0008152 Metabolic process
Process GO:0008219 Cell death
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0009605 Response to external stimulus
Process GO:0009611 Response to wounding
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009790 Embryo development
Process GO:0009792 Embryo development ending in birth or egg hatching
Process GO:0009887 Animal organ morphogenesis
Process GO:0009888 Tissue development
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010468 Regulation of gene expression
Process GO:0010517 Regulation of phospholipase activity
Process GO:0010518 Positive regulation of phospholipase activity
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010810 Regulation of cell-substrate adhesion
Process GO:0010811 Positive regulation of cell-substrate adhesion
Process GO:0010941 Regulation of cell death
Process GO:0010942 Positive regulation of cell death
Process GO:0010950 Positive regulation of endopeptidase activity
Process GO:0010952 Positive regulation of peptidase activity
Process GO:0012501 Programmed cell death
Process GO:0016043 Cellular component organization
Process GO:0016477 Cell migration
Process GO:0019216 Regulation of lipid metabolic process
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0022414 Reproductive process
Process GO:0022603 Regulation of anatomical structure morphogenesis
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0030154 Cell differentiation
Process GO:0030155 Regulation of cell adhesion
Process GO:0030162 Regulation of proteolysis
Process GO:0030198 Extracellular matrix organization
Process GO:0030278 Regulation of ossification
Process GO:0030334 Regulation of cell migration
Process GO:0030335 Positive regulation of cell migration
Process GO:0030500 Regulation of bone mineralization
Process GO:0030501 Positive regulation of bone mineralization
Process GO:0030510 Regulation of BMP signaling pathway
Process GO:0030513 Positive regulation of BMP signaling pathway
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031399 Regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032642 Regulation of chemokine production
Process GO:0032651 Regulation of interleukin-1 beta production
Process GO:0032652 Regulation of interleukin-1 production
Process GO:0032660 Regulation of interleukin-17 production
Process GO:0032675 Regulation of interleukin-6 production
Process GO:0032680 Regulation of tumor necrosis factor production
Process GO:0032722 Positive regulation of chemokine production
Process GO:0032731 Positive regulation of interleukin-1 beta production
Process GO:0032732 Positive regulation of interleukin-1 production
Process GO:0032740 Positive regulation of interleukin-17 production
Process GO:0032755 Positive regulation of interleukin-6 production
Process GO:0032760 Positive regulation of tumor necrosis factor production
Process GO:0033674 Positive regulation of kinase activity
Process GO:0033688 Regulation of osteoblast proliferation
Process GO:0033690 Positive regulation of osteoblast proliferation
Process GO:0034248 Regulation of cellular amide metabolic process
Process GO:0034250 Positive regulation of cellular amide metabolic process
Process GO:0035239 Tube morphogenesis
Process GO:0035295 Tube development
Process GO:0040011 Locomotion
Process GO:0040012 Regulation of locomotion
Process GO:0040017 Positive regulation of locomotion
Process GO:0042060 Wound healing
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042325 Regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042330 Taxis
Process GO:0042981 Regulation of apoptotic process
Process GO:0043009 Chordate embryonic development
Process GO:0043062 Extracellular structure organization
Process GO:0043065 Positive regulation of apoptotic process
Process GO:0043066 Negative regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043068 Positive regulation of programmed cell death
Process GO:0043069 Negative regulation of programmed cell death
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043280 Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process
Process GO:0043281 Regulation of cysteine-type endopeptidase activity involved in apoptotic process
Process GO:0043408 Regulation of MAPK cascade
Process GO:0043549 Regulation of kinase activity
Process GO:0044087 Regulation of cellular component biogenesis
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044319 Wound healing, spreading of cells
Process GO:0045229 External encapsulating structure organization
Process GO:0045595 Regulation of cell differentiation
Process GO:0045597 Positive regulation of cell differentiation
Process GO:0045667 Regulation of osteoblast differentiation
Process GO:0045669 Positive regulation of osteoblast differentiation
Process GO:0045765 Regulation of angiogenesis
Process GO:0045766 Positive regulation of angiogenesis
Process GO:0045778 Positive regulation of ossification
Process GO:0045785 Positive regulation of cell adhesion
Process GO:0045834 Positive regulation of lipid metabolic process
Process GO:0045859 Regulation of protein kinase activity
Process GO:0045860 Positive regulation of protein kinase activity
Process GO:0045862 Positive regulation of proteolysis
Process GO:0045893 Positive regulation of transcription, DNA-templated
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045944 Positive regulation of transcription by RNA polymerase II
Process GO:0046889 Positive regulation of lipid biosynthetic process
Process GO:0046890 Regulation of lipid biosynthetic process
Process GO:0048513 Animal organ development
Process GO:0048514 Blood vessel morphogenesis
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048568 Embryonic organ development
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048598 Embryonic morphogenesis
Process GO:0048608 Reproductive structure development
Process GO:0048646 Anatomical structure formation involved in morphogenesis
Process GO:0048729 Tissue morphogenesis
Process GO:0048731 System development
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0048870 Cell motility
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050896 Response to stimulus
Process GO:0051094 Positive regulation of developmental process
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051216 Cartilage development
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051254 Positive regulation of RNA metabolic process
Process GO:0051336 Regulation of hydrolase activity
Process GO:0051338 Regulation of transferase activity
Process GO:0051345 Positive regulation of hydrolase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051716 Cellular response to stimulus
Process GO:0052547 Regulation of peptidase activity
Process GO:0052548 Regulation of endopeptidase activity
Process GO:0060191 Regulation of lipase activity
Process GO:0060193 Positive regulation of lipase activity
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060411 Cardiac septum morphogenesis
Process GO:0060413 Atrial septum morphogenesis
Process GO:0060429 Epithelium development
Process GO:0060548 Negative regulation of cell death
Process GO:0060561 Apoptotic process involved in morphogenesis
Process GO:0060591 Chondroblast differentiation
Process GO:0060669 Embryonic placenta morphogenesis
Process GO:0060674 Placenta blood vessel development
Process GO:0060710 Chorio-allantoic fusion
Process GO:0060711 Labyrinthine layer development
Process GO:0060713 Labyrinthine layer morphogenesis
Process GO:0060716 Labyrinthine layer blood vessel development
Process GO:0061035 Regulation of cartilage development
Process GO:0061036 Positive regulation of cartilage development
Process GO:0061448 Connective tissue development
Process GO:0061458 Reproductive system development
Process GO:0065007 Biological regulation
Process GO:0065009 Regulation of molecular function
Process GO:0070167 Regulation of biomineral tissue development
Process GO:0070169 Positive regulation of biomineral tissue development
Process GO:0070372 Regulation of ERK1 and ERK2 cascade
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0072359 Circulatory system development
Process GO:0072593 Reactive oxygen species metabolic process
Process GO:0080090 Regulation of primary metabolic process
Process GO:0090092 Regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
Process GO:0090100 Positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
Process GO:0090153 Regulation of sphingolipid biosynthetic process
Process GO:0090154 Positive regulation of sphingolipid biosynthetic process
Process GO:0090287 Regulation of cellular response to growth factor stimulus
Process GO:0090504 Epiboly
Process GO:0090505 Epiboly involved in wound healing
Process GO:0098609 Cell-cell adhesion
Process GO:0110149 Regulation of biomineralization
Process GO:0110151 Positive regulation of biomineralization
Process GO:1901342 Regulation of vasculature development
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902680 Positive regulation of RNA biosynthetic process
Process GO:1902742 Apoptotic process involved in development
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903508 Positive regulation of nucleic acid-templated transcription
Process GO:1903555 Regulation of tumor necrosis factor superfamily cytokine production
Process GO:1903557 Positive regulation of tumor necrosis factor superfamily cytokine production
Process GO:1904018 Positive regulation of vasculature development
Process GO:1905038 Regulation of membrane lipid metabolic process
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000116 Regulation of cysteine-type endopeptidase activity
Process GO:2000145 Regulation of cell motility
Process GO:2000147 Positive regulation of cell motility
Process GO:2000303 Regulation of ceramide biosynthetic process
Process GO:2000304 Positive regulation of ceramide biosynthetic process
Process GO:2000307 Regulation of tumor necrosis factor (ligand) superfamily member 11 production
Process GO:2000309 Positive regulation of tumor necrosis factor (ligand) superfamily member 11 production
Process GO:2000341 Regulation of chemokine (C-X-C motif) ligand 2 production
Process GO:2000343 Positive regulation of chemokine (C-X-C motif) ligand 2 production
Process GO:2001056 Positive regulation of cysteine-type endopeptidase activity
Process GO:2001141 Regulation of RNA biosynthetic process
Component GO:0005576 Extracellular region
Component GO:0030312 External encapsulating structure
Component GO:0031012 Extracellular matrix
Component GO:0071944 Cell periphery
Component GO:0110165 Cellular anatomical entity
Function GO:0005102 Signaling receptor binding
Function GO:0005178 Integrin binding
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0005539 Glycosaminoglycan binding
Function GO:0008201 Heparin binding
Function GO:0019838 Growth factor binding
Function GO:0044877 Protein-containing complex binding
Function GO:0050839 Cell adhesion molecule binding
Function GO:0050840 Extracellular matrix binding
Function GO:0097367 Carbohydrate derivative binding
Function GO:1901681 Sulfur compound binding

Pathway annotation


Category Term ID Term description
RCTM RNO-381426 Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
RCTM RNO-392499 Metabolism of proteins
RCTM RNO-597592 Post-translational protein modification
RCTM RNO-8957275 Post-translational protein phosphorylation
WikiPathways WP442 Hypertrophy model

Expression profile of Ccn1 in omics data



ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.320226
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.392804
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.344168
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.422801
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.311944
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.414161
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.542441
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.412108
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.472057
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.728734
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.383962
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.375666
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.332104
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.492888
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.396681
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.477008
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.412181
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.390088
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.678493
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.396659
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.217962
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.42617
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.325453
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.388597
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.375174
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.511275
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.633571
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.075033
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.972256
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.485953
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.406381
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.23118
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.391102
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.429089
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.412108
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.822927
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.375594
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.381185
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.720999
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.899383
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.403473
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.311362
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.332953
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.332989
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.292951

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 10.35348
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 5.313802
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 9.586504
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 6.152234